
Venkataraman Balasubramanian
Examiner (ID: 17374, Phone: (571)272-0662 , Office: P/1624 )
Most Active Art Unit | 1624 |
Art Unit(s) | 1624, 1611 |
Total Applications | 2999 |
Issued Applications | 2017 |
Pending Applications | 254 |
Abandoned Applications | 728 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 4596624
[patent_doc_number] => 07982062
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-07-19
[patent_title] => 'Process for the preparation of cholanic acids'
[patent_app_type] => utility
[patent_app_number] => 11/853632
[patent_app_country] => US
[patent_app_date] => 2007-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1490
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/982/07982062.pdf
[firstpage_image] =>[orig_patent_app_number] => 11853632
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/853632 | Process for the preparation of cholanic acids | Sep 10, 2007 | Issued |
Array
(
[id] => 5198671
[patent_doc_number] => 20070297989
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-27
[patent_title] => 'NOVEL ANTI-INFLAMMATORY ANDROSTANE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 11/851125
[patent_app_country] => US
[patent_app_date] => 2007-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11434
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0297/20070297989.pdf
[firstpage_image] =>[orig_patent_app_number] => 11851125
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/851125 | NOVEL ANTI-INFLAMMATORY ANDROSTANE DERIVATIVES | Sep 5, 2007 | Abandoned |
Array
(
[id] => 4904538
[patent_doc_number] => 20080113952
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-15
[patent_title] => 'Combination Therapy For Treating Heart Disease'
[patent_app_type] => utility
[patent_app_number] => 11/847660
[patent_app_country] => US
[patent_app_date] => 2007-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9695
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20080113952.pdf
[firstpage_image] =>[orig_patent_app_number] => 11847660
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/847660 | Combination Therapy For Treating Heart Disease | Aug 29, 2007 | Abandoned |
Array
(
[id] => 4728032
[patent_doc_number] => 20080207576
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-28
[patent_title] => 'Substituted sapogenins and their use'
[patent_app_type] => utility
[patent_app_number] => 11/895095
[patent_app_country] => US
[patent_app_date] => 2007-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10518
[patent_no_of_claims] => 93
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20080207576.pdf
[firstpage_image] =>[orig_patent_app_number] => 11895095
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/895095 | Substituted sapogenins and their use | Aug 22, 2007 | Abandoned |
Array
(
[id] => 7724361
[patent_doc_number] => 08097632
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-01-17
[patent_title] => 'Inhibitors of hedgehog signaling pathways, compositions and uses related thereto'
[patent_app_type] => utility
[patent_app_number] => 11/894712
[patent_app_country] => US
[patent_app_date] => 2007-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 53
[patent_no_of_words] => 39057
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/097/08097632.pdf
[firstpage_image] =>[orig_patent_app_number] => 11894712
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/894712 | Inhibitors of hedgehog signaling pathways, compositions and uses related thereto | Aug 19, 2007 | Issued |
Array
(
[id] => 4860662
[patent_doc_number] => 20080269512
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-30
[patent_title] => 'Large Scale Method for the deoxofluorination of ketones'
[patent_app_type] => utility
[patent_app_number] => 11/841202
[patent_app_country] => US
[patent_app_date] => 2007-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2578
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20080269512.pdf
[firstpage_image] =>[orig_patent_app_number] => 11841202
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/841202 | Large Scale Method for the deoxofluorination of ketones | Aug 19, 2007 | Abandoned |
Array
(
[id] => 4734431
[patent_doc_number] => 20080051411
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-28
[patent_title] => 'Salts of Fenofibric Acid and Pharmaceutical Formulations Thereof'
[patent_app_type] => utility
[patent_app_number] => 11/840477
[patent_app_country] => US
[patent_app_date] => 2007-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16534
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0051/20080051411.pdf
[firstpage_image] =>[orig_patent_app_number] => 11840477
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/840477 | Salts of Fenofibric Acid and Pharmaceutical Formulations Thereof | Aug 16, 2007 | Abandoned |
Array
(
[id] => 4688775
[patent_doc_number] => 20080032956
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-07
[patent_title] => '2-Ethyl and 2-Ethylidene-19-Nor-Vitamin D Compounds'
[patent_app_type] => utility
[patent_app_number] => 11/839586
[patent_app_country] => US
[patent_app_date] => 2007-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 8082
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20080032956.pdf
[firstpage_image] =>[orig_patent_app_number] => 11839586
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/839586 | 2-ethyl and 2-ethylidene-19-nor-vitamin D compounds | Aug 15, 2007 | Issued |
Array
(
[id] => 4899832
[patent_doc_number] => 20080119446
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-22
[patent_title] => 'Prodrugs for Use as Ophthalmic Agents'
[patent_app_type] => utility
[patent_app_number] => 11/838676
[patent_app_country] => US
[patent_app_date] => 2007-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11151
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20080119446.pdf
[firstpage_image] =>[orig_patent_app_number] => 11838676
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/838676 | Quinol compound and pharmaceutical composition | Aug 13, 2007 | Issued |
Array
(
[id] => 4933475
[patent_doc_number] => 20080004250
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-03
[patent_title] => 'Compounds and Formulations'
[patent_app_type] => utility
[patent_app_number] => 11/838154
[patent_app_country] => US
[patent_app_date] => 2007-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16875
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20080004250.pdf
[firstpage_image] =>[orig_patent_app_number] => 11838154
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/838154 | Steroids having 1,8-unsaturation and formulations comprising same | Aug 12, 2007 | Issued |
Array
(
[id] => 4797886
[patent_doc_number] => 20080009472
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-10
[patent_title] => 'Prostate Cancer Treatment'
[patent_app_type] => utility
[patent_app_number] => 11/837508
[patent_app_country] => US
[patent_app_date] => 2007-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16871
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20080009472.pdf
[firstpage_image] =>[orig_patent_app_number] => 11837508
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/837508 | Prostate cancer treatment | Aug 10, 2007 | Issued |
Array
(
[id] => 6626172
[patent_doc_number] => 20100172870
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-08
[patent_title] => 'METHODS, USES AND COMPOSITIONS FOR MODULATING REPLICATION OF HCV THROUGH THE FARNESOID X RECEPTOR (FXR) ACTIVATION OR INHIBITION'
[patent_app_type] => utility
[patent_app_number] => 12/377169
[patent_app_country] => US
[patent_app_date] => 2007-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 21818
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0172/20100172870.pdf
[firstpage_image] =>[orig_patent_app_number] => 12377169
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/377169 | METHODS, USES AND COMPOSITIONS FOR MODULATING REPLICATION OF HCV THROUGH THE FARNESOID X RECEPTOR (FXR) ACTIVATION OR INHIBITION | Aug 7, 2007 | Abandoned |
Array
(
[id] => 5199138
[patent_doc_number] => 20070298456
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-27
[patent_title] => 'Microbiological process for the production of 7-substitued 11-hydroxy steroids, 7,17-substituted 11-halogen steroids, and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/826633
[patent_app_country] => US
[patent_app_date] => 2007-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10687
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0298/20070298456.pdf
[firstpage_image] =>[orig_patent_app_number] => 11826633
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/826633 | Microbiological process for the production of 7-substitued 11-hydroxy steroids, 7,17-substituted 11-halogen steroids, and uses thereof | Jul 16, 2007 | Abandoned |
Array
(
[id] => 4894020
[patent_doc_number] => 20080103119
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-01
[patent_title] => 'CARBONATE AND CARBAMATE MODIFIED FORMS OF GLUCOCORTICOIDS IN COMBINATION WITH B2 ADRENERGIC AGONISTS'
[patent_app_type] => utility
[patent_app_number] => 11/777830
[patent_app_country] => US
[patent_app_date] => 2007-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5673
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0103/20080103119.pdf
[firstpage_image] =>[orig_patent_app_number] => 11777830
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/777830 | Carbonate and carbamate modified forms of glucocorticoids in combination with β2 adrenergic agonists | Jul 12, 2007 | Issued |
Array
(
[id] => 5016634
[patent_doc_number] => 20070259843
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-08
[patent_title] => 'Methods and Compositions for Treatment of Macular and Retinal Disease'
[patent_app_type] => utility
[patent_app_number] => 11/777825
[patent_app_country] => US
[patent_app_date] => 2007-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11182
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0259/20070259843.pdf
[firstpage_image] =>[orig_patent_app_number] => 11777825
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/777825 | Methods and compositions for treatment of macular and retinal disease | Jul 12, 2007 | Issued |
Array
(
[id] => 4803785
[patent_doc_number] => 20080015374
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-17
[patent_title] => 'METHOD FOR THE SYNTHESIS AND ISOLATION OF PHYTOSTEROL ESTERS'
[patent_app_type] => utility
[patent_app_number] => 11/776181
[patent_app_country] => US
[patent_app_date] => 2007-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4183
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20080015374.pdf
[firstpage_image] =>[orig_patent_app_number] => 11776181
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/776181 | METHOD FOR THE SYNTHESIS AND ISOLATION OF PHYTOSTEROL ESTERS | Jul 10, 2007 | Abandoned |
Array
(
[id] => 4880404
[patent_doc_number] => 20080153787
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-26
[patent_title] => '18-Methyl-19-norandrost-4-ene 17, 17-spiro ether (18-methyl-19-nor-20-spirox-4-en-3-one), and pharmaceutical products comprising the same'
[patent_app_type] => utility
[patent_app_number] => 11/769952
[patent_app_country] => US
[patent_app_date] => 2007-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6709
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20080153787.pdf
[firstpage_image] =>[orig_patent_app_number] => 11769952
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/769952 | 18-Methyl-19-norandrost-4-ene 17, 17-spiro ether (18-methyl-19-nor-20-spirox-4-en-3-one), and pharmaceutical products comprising the same | Jun 27, 2007 | Issued |
Array
(
[id] => 8690045
[patent_doc_number] => 08389573
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-03-05
[patent_title] => 'Glycyrrhetinic acid derivatives'
[patent_app_type] => utility
[patent_app_number] => 12/308798
[patent_app_country] => US
[patent_app_date] => 2007-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 23
[patent_no_of_words] => 25362
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12308798
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/308798 | Glycyrrhetinic acid derivatives | Jun 26, 2007 | Issued |
Array
(
[id] => 4846424
[patent_doc_number] => 20080182832
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-31
[patent_title] => 'Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions'
[patent_app_type] => utility
[patent_app_number] => 11/819517
[patent_app_country] => US
[patent_app_date] => 2007-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 49
[patent_figures_cnt] => 49
[patent_no_of_words] => 14395
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20080182832.pdf
[firstpage_image] =>[orig_patent_app_number] => 11819517
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/819517 | Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions | Jun 26, 2007 | Issued |
Array
(
[id] => 4853172
[patent_doc_number] => 20080318915
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-25
[patent_title] => 'DEUTERIUM-ENRICHED FLUTICASONE PROPIONATE'
[patent_app_type] => utility
[patent_app_number] => 11/765657
[patent_app_country] => US
[patent_app_date] => 2007-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2925
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0318/20080318915.pdf
[firstpage_image] =>[orig_patent_app_number] => 11765657
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/765657 | DEUTERIUM-ENRICHED FLUTICASONE PROPIONATE | Jun 19, 2007 | Abandoned |